Search
01/06/2024
Apolipoproteins and Lipoproteins in Health and Disease 2.0
Rotllan, N, Escolà-Gil, JC. Apolipoproteins and Lipoproteins in Health and Disease 2.0. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(11)DOI:10.3390/ijms25116183. PMID:38892369. IF:4.900(Q1/3D).
01/06/2024
Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes
Illana, FJ, García-Osuna, A, Sospedra, M, Ferrer, R, Martínez-Brú, C, Guiñón, L. Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes. Biochemia Medica. 2024; 34(2)DOI:10.11613/BM.2024.020704. PMID:38665870. IF:1.800(Q3/6D).
01/06/2024
Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia
Lhoëst, MTL, Samouillan, V, García, E, Amaro, AB, Dandurand, J, Dato, VA, Guerra, JM, Escolà-Gil, JC, Chiabrando, G, Enrich, C. Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024
Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review
Masson, W, Barbagelata, L, Godinez-Leiva, E, Genua, I, Nogueira, JP. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review. Indian Journal Of Gastroenterology. 2024; 43(3)DOI:10.1007/s12664-023-01457-2. PMID:38036914. IF:(Q/D).